-+ 0.00%
-+ 0.00%
-+ 0.00%

Silexion Therapeutics Q4 EPS $(1.40) Misses $(1.07) Estimate

Benzinga·03/17/2026 21:16:48
Listen to the news
Silexion Therapeutics (NASDAQ:SLXN) reported quarterly losses of $(1.40) per share which missed the analyst consensus estimate of $(1.07) by 30.84 percent. This is a 100.66 percent decrease over earnings of $213.60 per share from the same period last year.